H

Hextar Healthcare Bhd
KLSE:HEXTAR

Watchlist Manager
Hextar Healthcare Bhd
KLSE:HEXTAR
Watchlist
Price: 0.89 MYR -1.11% Market Closed
Market Cap: 3.5B MYR
Have any thoughts about
Hextar Healthcare Bhd?
Write Note
Section:
 

Relative Value

The Relative Value of one HEXTAR stock under the Base Case scenario is 0.63 MYR. Compared to the current market price of 0.89 MYR, Hextar Healthcare Bhd is Overvalued by 29%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

HEXTAR Relative Value
Base Case
0.63 MYR
Overvaluation 29%
Relative Value
Price
H
Worst Case
Base Case
Best Case

Valuation Multiples

3.7
P/S
P/S
Price to Sales
3.7
vs History
52
vs Industry
2
Median 3Y
4.5
Median 5Y
3.8
Industry
1.1
Forward
4.5
More Details
47.8
P/E
P/E
Price to Earnings
47.8
vs History
57
vs Industry
Median 3Y
52
Median 5Y
51
Industry
17
Forward
46.4
More Details
42.2
P/OCF
P/OCF
Price to OCF
42.2
vs History
30
vs Industry
Median 3Y
40.5
Median 5Y
29.4
Industry
11.9
More Details
25.3
P/FCFE
P/FCFE
Price to FCFE
25.3
vs History
44
vs Industry
Median 3Y
33.6
Median 5Y
23.7
Industry
17.5
More Details
13.8
P/B
P/B
Price to Book Value
13.8
vs History
11
vs Industry
7
Median 3Y
12.9
Median 5Y
9.9
Industry
1.6
More Details
4
EV/S
EV/S
Enterprise Value to Sales
4
vs History
55
vs Industry
3
Median 3Y
4.8
Median 5Y
4.2
Industry
1.2
Forward
4.9
More Details
13.9
EV/GP
EV/GP
Enterprise Value to Gross Profit
13.9
vs History
63
vs Industry
3
Median 3Y
17.6
Median 5Y
15.8
Industry
3.9
More Details
22.5
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
22.5
vs History
74
vs Industry
Median 3Y
29.8
Median 5Y
26.7
Industry
10.4
Forward
27.1
More Details
25.3
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
25.3
vs History
71
vs Industry
Median 3Y
34.5
Median 5Y
29.3
Industry
13.2
More Details
45.8
EV/OCF
EV/OCF
Enterprise Value to OCF
45.8
vs History
30
vs Industry
Median 3Y
43.6
Median 5Y
31.1
Industry
12.2
More Details
53.6
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
53.6
vs History
25
vs Industry
Median 3Y
48.6
Median 5Y
32.1
Industry
15.5
More Details
5.2
EV/IC
EV/IC
Enterprise Value to IC
5.2
vs History
25
vs Industry
8
Median 3Y
5.2
Median 5Y
4.6
Industry
1.2
More Details

Multiples Across Competitors

HEXTAR Competitors Multiples
Hextar Healthcare Bhd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
MY
Hextar Healthcare Bhd
KLSE:HEXTAR
3.4B MYR 3.7 47.8 22.5 25.3
US
Procter & Gamble Co
NYSE:PG
398.2B USD 4.7 28.4 17.7 20.3
US
Colgate-Palmolive Co
NYSE:CL
75.8B USD 3.8 26.4 16.7 19.1
US
Kimberly-Clark Corp
NYSE:KMB
43.5B USD 2.2 16.7 10.9 13
UK
Reckitt Benckiser Group PLC
LSE:RKT
33.7B GBP 2.4 21.8 9.2 12.8
DE
Henkel AG & Co KGaA
XETRA:HEN3
35B EUR 1.6 26.6 10.1 13.8
US
Church & Dwight Co Inc
NYSE:CHD
25.9B USD 4.3 47.2 20.1 24.4
US
Clorox Co
NYSE:CLX
20B USD 2.7 56 15.7 18.7
SE
Essity AB (publ)
STO:ESSITY B
207.1B SEK 1.7 9.9 9.3 12.3
JP
Unicharm Corp
TSE:8113
2.3T JPY 2.4 27.2 10.8 14.4
US
Reynolds Consumer Products Inc
NASDAQ:REYN
5.8B USD 1.6 15.6 10.5 12.9

See Also

Summary
HEXTAR intrinsic value, competitors valuation, and company profile.
DCF Valuation
HEXTAR stock valuation using Discount Cash Flow valuation method.
Relative Valuation
HEXTAR stock valuation using valuation multiples.
Wall Street Estimates
HEXTAR price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
HEXTAR stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 209,300+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.